Prescribing, Policies and Pathways
The last day of operation for Hertfordshire and West Essex ICB was 31 March 2026. The information on this website has not been updated since 31 March 2026. The legacy policies, prescribing recommendations and pathways can be accessed on this website. Find out more
or
| Medicine / Guideline | Indication | RAG rating | Document type | Place |
|---|---|---|---|---|
| Access To Mental Health Services Guidance | n/a | Decision document | East and North Hertfordshire, South and West Hertfordshire, West Essex | |
| ADHD | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB | |
| Agomelatine | Major depressive episodes | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Antipsychotic depot injections | Schizophrenia | Red | n/a | Hertfordshire and West Essex ICB |
| Aripiprazole | Moderate to severe manic episodes in adolescents with bipolar I disorder | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Attention deficit hyperactivity disorder (ADHD) | ADHD shared care protocol children and young people (methylphenidate, lisdexamfetamine, dexamfetamine, atomoxetine or guanfacine) | Amber protocol | Shared care protocol | West Essex |
| Behavioural and Psychological Symptoms of Dementia (BPSD) | Dementia | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Buprenorphine oral lyophilisate | Opioid drug dependence | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Clonidine | Attention deficit hyperactivity disorder (ADHD) | Red | Decision document | Hertfordshire and West Essex ICB |
| Clozapine | Schizophrenia | Red | n/a | Hertfordshire and West Essex ICB |
| CYP Eating Disorders and Emotional Distress | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Dementia | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Depression | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Dosulepin | Depression | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Dosulepin Patient Information Leaflet | Depression | n/a | Patient information | Hertfordshire and West Essex ICB |
| Eating Disorders | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Esketamine | Depression - major | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Guidelines on Choice and Selection of Antidepressants for the Management of Depression | Depression | n/a | Prescribing guideline | East and North Hertfordshire, South and West Hertfordshire |
| Lithium | Mania, hypomania, bipolar disorder, depression and aggressive or self-harming behaviour | Amber protocol | Shared care protocol | West Essex |
| Lithium | Mania, hypomania, bipolar disorder, depression and aggressive or self-harming behaviour | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Lithium Primary Care action plan | Mania, hypomania, bipolar disorder, depression and aggressive or self-harming behaviour | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Loxapine | Acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Lurasidone | Schizophrenia | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Mirtazapine dose optimisation switch patient letter | Green | Patient information | Hertfordshire and West Essex ICB | |
| Pathological Demand Avoidance | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Q&A for Prescribing of Antidepressants for Depression | Depression | n/a | Prescribing support document | Hertfordshire and West Essex ICB |
| Quetiapine | Schizophrenia and bipolar disorder | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Risperidone dose optimisation switch patient letter | Green | Decision document | Hertfordshire and West Essex ICB | |
| Sodium valproate | All indications | Amber initiation | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Suicide Prevention | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Transcranial Magnetic Stimulation (TMS and rTMS) | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Trimipramine | Depression | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Trimipramine | Depression | n/a | Patient information | Hertfordshire and West Essex ICB |
| Venlafaxine | Depression, anxiety and panic disorders | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Vortioxetine | Major depressive episodes | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |